With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Autophagy and mTOR Inhibition in Pediatric Gliomas with BRAF Mutations||University of Colorado Denver / Jean Mulcahy Levy, MD||Young Investigator Grants||2014||Colorado|
|B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers||University of Texas Southwestern Medical Center / James Amatruda, MD, PhD||Reach Grants||2013||Texas|
|Bad Influence: EWS/FLI Alters LSD1 and NuRD Interactions to Enforce Oncogenic Function in Ewing’s||Research Institute at Nationwide Children's Hospital / Emily Theisen, PhD||Young Investigator Grants||2016||Ohio|
|Barcoding Pediatric Leukemia for Therapeutic Purposes||Boston Children's Hospital / Leonard Zon, MD||Crazy 8 Awards||2021||Massachusetts|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|
|BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia||Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD||'A' Award Grants||2012||New York|
|Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant||Children's Hospital of Philadelphia / Caitlin Elgarten, MD||Young Investigator Grants||2018||Pennsylvania|
|BH3 Profiling to define therapy resistance classes in neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Innovation Grants||2011||Pennsylvania|
|BH3 profiling to define therapy resistance classes in neuroblastoma.||Children's Hospital of Philadelphia / Michael Hogarty||Innovation Grants||2009||Pennsylvania|
|Biology-based clinical trials for children with cancer.||Children's Hospital of Philadelphia / Rochelle Bagatell||Phase I/II Infrastructure Grants||2009||Pennsylvania|